Jane Street Group, LLC Inovio Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.35 - $0.53 $67,606 - $102,375	193,161 Added 71.9%	461,811 $235,000
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.58 $1.11 Million - $1.7 Million	-2,927,431 Reduced 91.59%	268,650 $104,000
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.94 $882,164 - $2.13 Million	2,261,961 Added 242.15%	3,196,081 $1.44 Million
Q1 2023 May 15, 2023	BUY	$0.79 - $1.91 $493,370 - $1.19 Million	624,519 Added 201.72%	934,120 $765,000
Q4 2022 Feb 14, 2023	BUY	$1.41 - $2.5 $380,305 - $674,300	269,720 Added 676.31%	309,601 $482,000
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $170,241 - $286,128	-102,555 Reduced 72.0%	39,881 $69,000
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $170,241 - $286,128	-102,555 Reduced 72.0%	39,881 $69,000
Q2 2022 Aug 16, 2022	SELL	$1.44 - $3.98 $243,168 - $672,090	-168,867 Reduced 54.25%	142,436 $246,000
Q1 2022 May 17, 2022	BUY	$2.97 - $5.2 $611,998 - $1.07 Million	206,060 Added 195.79%	311,303 $1.12 Million
Q4 2021 Feb 15, 2022	BUY	$4.99 - $7.46 $235,742 - $352,432	47,243 Added 81.45%	105,243 $525,000
Q3 2021 Nov 16, 2021	BUY	$7.16 - $9.69 $179,494 - $242,918	25,069 Added 76.13%	58,000 $415,000
Q2 2021 Aug 16, 2021	SELL	$6.23 - $10.03 $69,202 - $111,413	-11,108 Reduced 25.22%	32,931 $306,000
Q1 2021 May 18, 2021	SELL	$8.81 - $16.96 $3.63 Million - $7 Million	-412,443 Reduced 90.35%	44,039 $409,000
Q4 2020 Feb 17, 2021	BUY	$8.5 - $12.85 $702,567 - $1.06 Million	82,655 Added 22.11%	456,482 $4.04 Million
Q3 2020 Nov 17, 2020	SELL	$9.57 - $27.05 $4.7 Million - $13.3 Million	-491,411 Reduced 56.79%	373,827 $4.34 Million
Q2 2020 Aug 17, 2020	BUY	$7.14 - $31.69 $6.07 Million - $26.9 Million	849,761 Added 5490.48%	865,238 $23.3 Million
Q1 2020 May 15, 2020	BUY	$2.98 - $14.09 $46,121 - $218,070	15,477 New	15,477 $115,000
Q4 2019 Feb 14, 2020	SELL	$1.97 - $3.72 $58,688 - $110,822	-29,791 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.05 - $3.02 $130,923 - $192,872	-63,865 Reduced 68.19%	29,791 $61,000
Q2 2019 Aug 15, 2019	BUY	$2.29 - $4.1 $214,472 - $383,989	93,656 New	93,656 $275,000
Q4 2018 Feb 15, 2019	SELL	$3.89 - $6.11 $45,948 - $72,171	-11,812 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.92 - $5.58 $46,303 - $65,910	11,812 New	11,812 $66,000
Q2 2018 Aug 15, 2018	SELL	$3.88 - $5.16 $61,001 - $81,125	-15,722 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.05 - $5.69 $3,936 - $5,530	972 Added 6.59%	15,722 $74,000
Q4 2017 Feb 15, 2018	BUY	$4.13 - $6.68 $60,917 - $98,530	14,750	14,750 $61,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account